secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001104659-22-073063
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Interim CFO Susan L. Drexler resigns; CEO assumes principal financial officer role
--------------------------------------------------------------------------------

- Susan L. Drexler resigned as Interim CFO effective June 16, 2022, but remains a consultant.
- Resignation not due to any disagreement with company operations, policies, or practices.
- CEO Brian M. Strem, Ph.D., becomes principal financial and accounting officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922073063/0001104659-22-073063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000110465922073063/tm2219040d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-073063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer